Jing‐Yi Chern

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Is age-related worsening in ovarian cancer prognosis linked to changes in body composition and pharmacokinetics?”.

Is age-related worsening in ovarian cancer prognosis linked to changes in body composition and pharmacokinetics?

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e17553

N/A

0DataRank · unranked

0 citations

Christine M. Walko, Asmita Mishra, Kerry Thomas, Biwei Cao, Hye Sook Chon +9 more

A randomized phase II study of bevacizumab and weekly anetumab ravtansine or weekly paclitaxel in platinum-resistant or refractory ovarian cancer NCI trial#10150.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.5514

N/A

0DataRank · unranked

22 citations

Husam Alqaisi, David E. Cohn, Jing‐Yi Chern, Linda Duska, Andrea Jewell +15 more

Ovarian cancer: Age, prognosis, and biologic underpinnings.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e17555

N/A

0DataRank · unranked

0 citations

Biwei Cao, Anders Berglund, Jing‐Yi Chern, Hye Sook Chon, Mihaela Cristea +13 more

Retrotransposon methylation profiles and survival in Black women with high-grade serous ovarian carcinoma

Clinical Epigenetics(2025)10.1186/s13148-025-01942-9

N/A

0DataRank · unranked

0 citations

Katherine A. Lawson-Michod, Courtney E. Johnson, Irma Vlasac, Sean Yoder, Tania Mesa +22 more